Paralytics: Vecuronium / Norcuron Flashcards
Vecuronium is classified as which type of compound?
A) Di-quaternary am
B) Monoquaternary aminosteroid
39
What is the 2x ED95 dose for Vecuronium?
A) 0.05 mg/kg
B) 0.1 mg/kg
C) 0.2 mg/kg
D) 1 mg/kg
B) 0.1 mg/kg
39
After using Succinylcholine, what dose of Vecuronium is typically administered?
A) 0.1 mg/kg
B) 0.05 mg/kg
C) 1 mg/kg
D) 0.5 mg/kg
B) 0.05 mg/kg
39
What is the typical infusion rate for Vecuronium?
A) 0.5–1 mcg/kg/min
B) 1–2 mcg/kg/min
C) 2–3 mcg/kg/min
D) 5–10 mcg/kg/min
B) 1–2 mcg/kg/min
39
Why is Vecuronium not considered the best choice for infusion?
A) It has a rapid onset.
B) It does not accumulate in the body.
C) It may accumulate due to hepatic metabolism.
D) It is metabolized by the kidneys.
C) It may accumulate due to hepatic metabolism.
39
Vecuronium is supplied as a powder and is mixed with water to make a concentration of:
A) 1 mg/cc
B) 2 mg/cc
C) 0.5 mg/cc
D) 10 mg/cc
A) 1 mg/cc
39
What percentage of Vecuronium’s metabolism is hepatic?
A) 20-30%
B) 30-40%
C) 50-60%
D) 70-80%
B) 30-40%
39
What are the properties of Vecuronium’s metabolism and effects (select 3 that apply)?
A) It has an active metabolite.
B) It retains 80% potency of the parent compound.
C) It may accumulate in renal failure.
D) It has no active metabolites.
E) It is excreted entirely by the lungs.
A) It has an active metabolite
B) It retains 80% potency of the parent compound
C) It may accumulate in renal failure.
39
Put it all together
- Vecuronium is classified as a ___
- Vecuronium’s 2 x ED95 dose is ___ mg/kg.
- The dosing of Vecuronium after Succinylcholine is ___ mg/kg.
- The infusion rate for Vecuronium is __ mcg/kg/min.
- Vecuronium may not be suitable for continuous infusion because of ___.
- Vecuronium is supplied as a powder that needs to be mixed with water to create ___ mg/cc.
- Vecuronium undergoes hepatic metabolism, with approximately ___% of it metabolized by the liver.
- Vecuronium’s active metabolite retains ___% potency of the parent compound.
- Vecuronium may accumulate in patients with ___ failure.
- monoquaternary aminosteroid
- 0.1 mg/kg
- 0.05 mg/kg
- 1–2 mcg/kg/min
- accumulation
- 1 mg/cc
- 30–40%
- 80%
- renal failure
39